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Abstract
In a longitudinal cohort study of young Australian adults, we reported that for women higher baseline levels of ﬁsh consumption were
associated with reduced incidence of new depressive episodes during the 5-year follow-up. Fish are high in both n-3 fatty acids and tyrosine.
In this study, we seek to determine whether n-3 fatty acids or tyrosine explain the observed association. During 2004–2006, a FFQ (nine ﬁsh
items) was used to estimate weekly ﬁsh consumption among 546 women aged 26–36 years. A fasting blood sample was taken and high-
throughput NMR spectroscopy was used to measure 233 metabolites, including serum n-3 fatty acids and tyrosine. During 2009–2011, new
episodes of depression since baseline were identiﬁed using the lifetime version of the Composite International Diagnostic Interview. Relative
risks were calculated using log-binomial regression and indirect effects estimated using the STATA binary_mediation command. Potential
mediators were added to separate models, and mediation was quantiﬁed as the proportion of the total effect due to the mediator. The n-3
DHA mediated 25·3% of the association between ﬁsh consumption and depression when ﬁsh consumption was analysed as a continuous
variable and 16·6% when dichotomised (reference group: <2 serves/week). Tyrosine did not mediate the association (<0·1%). Components in
ﬁsh other than n-3 fatty acids and tyrosine might be beneﬁcial for women’s mental health.
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Depression is a common cause of disability(1). In the USA,
depression cost an estimated $210·5 billion in 2010 and resulted
in almost 400 million disability days during 2014(2). There is
increasing interest in whether lifestyle factors such as diet can
prevent or treat depression(3). A recent meta-analysis concluded
that high ﬁsh consumption could reduce the risk of depres-
sion(4). This raises the question of which component(s) of ﬁsh
are responsible for the protective effect(5).
One candidate is the n-3 PUFA, particularly the long-chain
EPA and DHA, which are highly available in ﬁsh(6), and DHA is
highly concentrated in the brain(7). The role of n-3 PUFA in
neurophysiology and depression has been investigated exten-
sively(8,9), and there is evidence suggesting that long-chain n-3
PUFA may be beneﬁcial in the prevention and treatment of
depression(9,10), although the mechanism is debated(8) and
there have not been enough randomised controlled trials
with sufﬁcient power to demonstrate this conclusively(11).
The ratio of n-6 PUFA to n-3 PUFA in erythrocytes has also
been associated with depression in some studies(12).
Another component of ﬁsh suggested to be beneﬁcial for
mental health is tyrosine(5), an amino acid that is particularly
abundant in some ﬁsh relative to other common forms of
dietary protein(13). Tyrosine is a precursor to dopamine, cate-
cholamines, melanins and thyroid hormones(13). Irregularities
in these systems have been associated with neurophysiological
and psychological problems, including depression(14–16).
Abbreviations: CDAH, Childhood Determinants of Adult Health; DGI, dietary guideline index; DV, dependent variable; LNAA, large neutral amino acids.
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Acute tyrosine depletion in healthy volunteers has been linked
to unipolar depression(17), and chronic low levels of tyrosine in
the brain have been associated with depression in longitudinal
studies of phenylketonuria(18). Tyrosine supplementation has
been studied as a possible treatment for depression with mixed
results(19). There has only been one randomised double-blind
trial; that study found that tyrosine supplementation was not an
effective treatment for depression(20).
We previously reported that, among women, higher baseline
ﬁsh consumption was associated with a lower risk of a new
depressive episode during the 5-year follow-up, an association
that remained robust when subjects with a history of depression
were excluded(21). Since publishing that paper, we have
conducted metabolomics analysis on stored blood samples. This
study investigates whether the protective association between ﬁsh
consumption and depression observed among young Australian
women is mediated by n-3 fatty acid status or tyrosine status.
Methods
Study population
The Childhood Determinants of Adult Health (CDAH) study is a
follow-up to the 1985 Australian Schools Health and Fitness
Survey, a nationally representative sample of 7- to 15-year-old
Australian schoolchildren (n 8498). Participants were traced
during 2001–2002 and 5170 enrolled in the CDAH study(22).
During 2004–2006, 2410 participants attended one of thirty-four
study clinics held around Australia for physical measurements,
aged 26–36 years (baseline for this analysis), and completed
questionnaires. The majority of these participants (64%) gave a
fasting blood sample, and the characteristics of this subset are
similar to the full set of participants (data not shown). In a
second follow-up conducted 5 years later (2009–2011), parti-
cipants completed written questionnaires and a telephone
interview (follow-up).
The study was conducted according to the guidelines
laid down in the Declaration of Helsinki, and all procedures
involving human participants were approved by the Southern
Tasmanian Health and Medical Ethics Committee. Written
informed consent was obtained from all participants.
Fish consumption
Fish consumption was assessed at baseline via a 127-item
FFQ(23), with nine items relating to ﬁsh and seafood (canned
ﬁsh, fresh ﬁsh, frozen ﬁsh, fried ﬁsh, mussels/oysters, lobster/
crayﬁsh/yabbies (small lobsters), calamari/squid, prawns and
other seafood)(21). The FFQ was based on a validated ques-
tionnaire developed for Australian adults(24,25) and was a
slightly modiﬁed version of the one used in the 1995 Australian
National Nutrition Survey(26). Participants were asked to recall
how frequently they consumed each item over the previous
12 months by selecting one of nine response items, ranging
from ‘never/less than once a month’ through to ‘6 or more times
a day’. Weekly equivalents were calculated on the assumption
that one serving was consumed on each occasion(23), and then
summed to determine the total weekly consumption of ﬁsh and
seafood (hereafter ‘weekly ﬁsh consumption’). Participants who
did not answer all of the ﬁsh questions were excluded from the
analysis.
Depression
At follow-up, participants completed the computerised lifetime
version of the Composite International Diagnostic Interview
(CIDI-Auto 2.1) via a computer-assisted telephone interview
designed for use by non-clinical interviewers. Major depression
or dysthymic disorder (hereafter ‘depression’) was deﬁned by
the Diagnostic and Statistical Manual of Mental Disorders,
Fourth Edition (DSM-IV). Age at the time of the most recent
episode was used to determine whether an episode had
occurred since baseline. Participants who had a new episode of
depression during the 5-year follow-up were compared with
those who did not have a new episode.
Metabolomics
Fasting blood samples collected at baseline were stored
at −80°C for 11–13 years before being analysed using the
Computational Medicine metabolomic platform(27,28), which used
high-throughput NMR spectroscopy to proﬁle the serum levels of
233 key metabolic markers. All samples were subjected to auto-
mated quality control, and values for any metabolic markers that
could not be extracted reliably were excluded from the
analysis(27,29). Here we focus on tyrosine, DHA, total n-3 PUFA
(including long-chain and short-chain n-3 PUFA) and total PUFA
(including both n-3 and n-6 PUFA). We also examined the
n-3:n-6 ratio, deﬁned as (total n-3 PUFA)/(total n-6 PUFA), which
includes both long- and SCFA. Although n-6:n-3 is the ratio more
commonly used, we use the inverse form (n-3:n-6) so that higher
values are associated with greater protection. In addition, we
examined the ratio of tyrosine:total concentration of large neutral
amino acids (LNAA), as tyrosine competes with LNAA for trans-
port across the blood–brain barrier(30). LNAA included tyrosine,
valine, leucine and isoleucine, but data for tryptophan were not
available. The CV for this technique were 2·7% for n-3 fatty acids
(2·7% for DHA) and 7·7% for tyrosine(31).
Covariates
At baseline, participants reported their marital status, education,
occupation and smoking status. Weight and height were mea-
sured at study clinics using portable digital scales (Heine) and a
portable stadiometer (Invicta). Height and weight were self-
reported by participants who did not visit a study clinic and a
correction factor was applied(32). BMI was calculated as
weight (kg) divided by the square of height (m2). Health status
was assessed using the twelve-Item Short-Form Health
Survey(33). Information from the FFQ and food habits ques-
tionnaire was used to create a dietary guideline index (DGI),
based on the Australian Guide to Healthy Eating(34) and the
Dietary Guidelines for Australian Adults(35). The DGI included
ﬁfteen components, scored from 0 to 10, with 10 indicating
optimal intake (total range, 0–150). The DGI has been shown to
be a valid measure of diet quality(36,37).
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Statistical analysis
For each metabolic marker of interest, mediation was assessed
using the four steps of mediation proposed by Baron &
Kenny(38). This method tests potential mediators by examining
the pathways from the independent variable to the mediator
and from the mediator to the dependent variable, as well as
considering the effect of controlling for the mediator on the
pathway from the independent variable to the dependent
variable. The four steps are as follows: (1) test whether the
independent variable is associated with the dependent variable;
(2) the independent variable is associated with the mediator;
(3) the mediator variable is associated with the dependent
variable; and (4) establish that the mediator variable mediates
the association between the independent and dependent
variables. In the ﬁrst step, we tested the direct pathway between
ﬁsh consumption (independent variable) and a new depressive
episode (dependent variable) to verify the association established
in our earlier study(21). For the second step, we tested the indivi-
dual associations between ﬁsh consumption (independent vari-
able) and each metabolic marker (potential mediators), examining
ﬁsh consumption as both a dichotomous and a continuous
variable. For the third step, we tested the pathway from each
metabolic marker (potential mediator) to depression (dependent
variable), using log-binomial regression in each case. Finally, for
the fourth step, we used the STATA binary_mediation command to
estimate the indirect effects due to each potential mediator, and
calculated this indirect effect as a proportion of the total effect.
Internally, the binary_mediation command uses linear regression
for continuous variables and (by default) logistic regression for
categorical variables. Note that for the last three steps separate
models were tested for each individual potential mediator.
For metabolites that passed all four mediation tests, we
conducted further sensitivity analyses by including additional
covariates in each model. Speciﬁcally, we included the same
covariates as the earlier study: marital status, smoking status,
weight status and self-rated health(21). To determine whether
diet quality was a confounder, we also included PUFA sup-
plementation, the DGI score and a modiﬁed DGI score (which
excluded ﬁsh items) in separate sensitivity analyses.
To determine whether the mediation effect of n-3 fatty acids
and tyrosine differed by smoking status, we included a multi-
plicative interaction term between smoking status and ﬁsh
intake. We found no evidence for interaction by smoking status,
with all interactions terms P> 0·33.
This study focuses on women, as our earlier study found that
ﬁsh consumption was not associated with depression among
men. STATA software (2012, version 12.1; StataCorp) was used
for all analyses.
Results
In total, 1552 women had data on baseline ﬁsh consumption.
We excluded those who did not complete the CIDI-Auto 2.1
interview (n 627), were missing covariate data (n 71), did not
give a blood sample (n 304) or were missing values for tyrosine
(n 4). The baseline characteristics of the 546 participants
included in the analysis are shown in Table 1.
In total, ninety-eight women had a depressive episode during
the 5-year follow-up. Although the study population was
smaller than our previous study(21), as not all participants gave a
blood sample, a similar association between ﬁsh consumption
and depression was found (7·6% lower risk of a new depressive
episode with every additional serve of ﬁsh), verifying Step 1 of
the Baron and Kenny mediation tests.
The results for the three remaining tests are summarised in
Table 2 in descending order of mediation, for the key metabolic
markers of interest, and in the online Supplementary Tables for
all metabolites. DHA was the only metabolic marker to pass all
three tests. DHA levels were positively associated with ﬁsh
consumption (continuous: β= 0·005, P< 0·001; dichotomous:
Table 1. Baseline characteristics among Australian women in the Child-
hood Determinants of Adult Health Study, stratified by depression status
during the 5-year follow-up
(Numbers and percentages; mean values and standard deviations)
No depression (n 448) Depression* (n 98)
Statistic† Statistic†
Characteristics n % n %
Age (years)
Mean 31·3 31·1
SD 2·7 2·6
Married or living as married 333 74·3 63 64·3
Education
University qualification 251 56·0 47 48·0
Vocational 95 21·2 16 16·3
High school or less 102 22·8 35 35·7
Occupation
Professional or manager 244 55·2 45 46·4
Non-manual 101 22·9 30 30·9
Manual 19 4·3 1 1·0
Not in the workforce 78 17·7 21 21·7
BMI (kg/m2)
Normal (<25) 293 65·4 60 61·2
Overweight (25–29·9) 108 24·1 21 21·4
Obese (≥30) 47 10·5 17 17·4
Fish intake
<2 serves/week 169 37·7 52 53·1
≥2 serves/week 279 62·3 46 46·9
Serves/week
Mean 2·81 2·38
SD 2·21 2·45
DHA (mmol/l)
Mean 0·16 0·15
SD 0·06 0·05
n-3 FA (mmol/l)
Mean 0·38 0·36
SD 0·10 0·08
PUFA (mmol/l)
Mean 3·83 3·69
SD 0·70 0·64
n-3:n-6
Mean 0·112 0·109
SD 0·02 0·02
Tyrosine (mmol/l)
Mean 0·05 0·05
SD 0·01 0·01
FA, fatty acids.
* New episode of depression in the preceding 5 years, as diagnosed by the Composite
International Diagnostic Interview (Composite International Diagnostic Interview-
Auto 2.1).
† Sample sizes vary owing to missing data (range 442–448 for women without
depression; 97–98 for women who had a depressive episode).
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β= 0·025, P< 0·001, Table 2) and negatively associated with
depression (β= − 3·87, P= 0·03). As a proportion of the total
effect, the indirect effect due to DHA was the highest of all
metabolites examined, estimated at 25% (continuous) and 17%
(dichotomous). The associations remained in the sensitivity
analyses when covariates were added to the models.
Tyrosine levels and the tyrosine:LNAA ratio were also positively
associated with ﬁsh consumption, although the effect sizes were
very small and NS (β< 0·001, P= 0·83 for tyrosine and β< 0·001,
P= 0·57 for tyrosine:LNAA, Table 2). However, rather than being
protective against depression, higher levels of tyrosine and the
tyrosine:LNAA ratio were associated with a higher risk of
depression, but again these associations were not signiﬁcant
(β= 0·84, P= 0·92 for tyrosine and β= 1·66, P= 0·75 for tyrosine:
LNAA). These associations were not sustained during sensitivity
testing when PUFA supplementation and the covariates from the
original study were included in the model. Tyrosine (but not
tyrosine:LNAA) passed all three mediation tests, but the propor-
tion of the total effect mediated by tyrosine was <1%.
Discussion
This study builds on our previous work that reported higher
baseline ﬁsh consumption was associated with a lower risk of a
new depressive episode among young women(21). In this study,
we have shown that the association is partially mediated by
baseline plasma levels of DHA but not tyrosine.
DHA only partially explained the protective role of ﬁsh
against depression, suggesting that there may be other com-
ponents in ﬁsh that are protective or there may be synergistic
effects between the nutrients in ﬁsh. The mediation proportion
for DHA was roughly three to four times higher than the highest
non-n-3 fatty acid-related metabolites. DHA passed all three
steps of the Baron and Kenny method for all models tested,
including models with smoking status and use of ﬁsh oil sup-
plements as covariates. We did not adjust for age or physical
activity, as these variables were not associated with depression
in this sample and therefore cannot be confounders(21), but
other unmeasured confounding is possible.
In the current study, total n-3 PUFA and the n-3:n-6 ratio did not
satisfy all criteria for mediation. The mediation effect for n-3 PUFA
was lower than that of DHA alone, probably because the effect of
DHA is diluted by the inclusion of n-3 PUFA that do not have a
protective effect against depression, such as α-linolenic acid.
To our knowledge, no previous studies have conducted
mediation analysis to identify the components in ﬁsh that
mediate the protective effect of ﬁsh on depression. Although we
do not have a measure for EPA in our study, our ﬁndings add to
the previous literature examining associations between plasma/
serum or dietary n-3 fatty acids and depression. A meta-analysis
of fourteen studies found that DHA, EPA and n-3 fatty acid
levels in plasma/serum were lower among patients with
depression than controls(4). A cross-sectional study in Japanese
adults (40+ years) found an inverse association between serum
DHA and EPA levels and depressive symptoms(39). Dietary
intake of DHA and EPA was found to be inversely associated
with the risk of depression symptoms after a 3-year follow-up in
the Coronary Artery Risk Development in Young Adults
(CARDIA) study(40). In contrast, several longitudinal studies
have reported no association between dietary intake of n-3
PUFA and depression(41–43). The conﬂicting results may reﬂect
the different methods used to assess ﬁsh intake and depression,
different ages of the samples (e.g. older adults or having a wide
age range) and unmeasured or residual confounding.
n-3 Fatty acid supplements have been tested in randomised
controlled trials as a possible treatment of depression, with
inconsistent results. Two recent meta-analyses published in
2016 have conﬂicting conclusions. A Cochrane systematic
Table 2. The mediation effect of n-3 fatty acids and tyrosine on the association between fish consumption at baseline and new
episodes of depression in the 5-year follow-up
Step 2*† Step 4*§
Fish>metabolite Step 3*‡ Mediation (%)
Metabolomic markers (Dichot.)|| (Cont.)¶ Metabolite> depression** (Dichot.) (Cont.)
DHA (mmol/l) 0·025†† 0·005†† −3·87†† 16·6 25·3
n-3 PUFA (mmol/l) 0·036†† 0·008†† −1·98 12·5 22·4
n-3:n-6 0·008†† 0·003 −5·11 6·0 15·4
Total PUFA (mmol/l) 0·093 0·000 −0·23 4·2 0·1
Tyrosine (mmol/l) 0·000 0·000 0·84 0·0 − 0·1
Tyrosine:LNAA 0·001 0·000 1·66 −0·2 − 0·6
Cont, continuous; Dichot, dichotomous; LNAA, large neutral amino acids.
* Mediation steps proposed by Baron & Kenny(38).
† Step 2: effect size of association between fish consumption (independent variable) and metabolic marker (dependent variable). The reported values are
β-coefficients.
‡ Step 3: effect size of association between metabolic marker (independent variable) and new episodes of depression during the 5-year period (dependent
variable). The reported values are β-coefficients.
§ Step 4: proportion of total effect mediated by metabolic marker when included as a covariate in a model with fish consumption (independent variable)
and depression (dependent variable), estimated using the binary_mediation STATA command.
|| Dichot: fish consumption treated as a categorical variable, comparing women who ate fish at least two times per week (n 325) at baseline compared with
women who consumed fish less than two times per week (n 221).
¶ Cont: fish consumption treated as a continuous variable (serves per week).
** Ninety-eight participants had a new depressive episode during the 5-year follow-up and 448 did not.
†† Statistically significant at P< 0·05.
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review and meta-analysis of twenty randomised controlled trials
found insufﬁcient evidence to support the use of n-3 fatty acid
supplements as a treatment for depression(11). Most studies
included in the review were small (all but three studies had
<100 participants), and of short duration (4–16 weeks). In
contrast, a meta-analysis of thirteen studies found a beneﬁcial
effect of n-3 fatty acid supplementation in patients with depres-
sion, especially for higher doses of EPA and when used in
combination with antidepressants(44). However, the beneﬁcial
effect was small, and it has been argued that the effect may not be
clinically important and the results were inﬂuenced by poorer-
quality studies(45).
There are several limitations that need to be considered. The
FFQ did not distinguish between fatty and non-fatty ﬁsh, and it is
possible that analysis focusing on fatty ﬁsh may reveal a stronger
association with depression, as well as a higher degree of med-
iation by n-3 PUFA. Data for one LNAA (tryptophan) were not
available, and therefore we overestimate the tyrosine:LNAA ratio.
There is the possibility that some metabolites may have degraded
as a result of long-term storage, but samples were subjected to
quality control. Of the 1940 participants who had blood samples
analysed from the CDAH study, seventeen (0·8%) were excluded
from the analysis for degraded n-3 fatty acids (eight women), and
twenty-seven (1·4%) for tyrosine (nine women). Compounds
representing lipid oxidation products were not detected in any of
the samples.
Another limitation was the difference in time scales between
the variables being compared. Although the FFQ assesses ﬁsh
consumption retrospectively over a 12-month period and
depression status was determined over a 5-year period, the
metabolomic data represent a snapshot of fasting plasma levels at
a single moment in time. This snapshot reﬂects dietary intake over
the previous few days, but different nutrients are metabolised at
different rates and so the degree to which fasting plasma meta-
bolite levels can be taken as a proxy for long-term consumption
may vary. Plasma and erythrocytes n-3 PUFA levels have both
been shown to correlate to short-term consumption(46). However,
tyrosine is rapidly metabolised in the body, with levels returning
to baseline within a few hours after a meal(47). Long-term con-
sumption patterns are difﬁcult to capture owing to tyrosine’s
multiple destinations in the body, although future studies with
more frequent measurements may provide a more accurate
picture. Long-term ﬁsh intake appears to be relatively stable in
this cohort, as sensitivity analyses in our previous study found
similar results when baseline and follow-up intake was averaged
and used as the exposure variable(21). Although it would have
been ideal to also examine EPA, DHA was the only long-chain
n-3 PUFA for which individual levels were available.
Data on lipid mediators or metabolites derived from PUFA
may help to clarify the role of PUFA in the association between
ﬁsh consumption and depression. However, EPA and lipid
mediators are unable to be distinguished by the NMR platform,
and complementary assays such as MS may be required. In
addition, we were unable to examine change in metabolites as
blood samples, and therefore the metabolite data were only
collected at baseline. The study population had higher repre-
sentation of professionals/managers and people married or
living as married than the general Australian population of similar
age. Although marital status or socio-economic status may play a
role in determining susceptibility of depression, these factors are
unlikely to affect how serum metabolites mediate the association
between diet and depression.
Major strengths of this study include the ability to compare
233 potential mediators in the same sample using a rigorous
and accepted method of mediation. Depression was
assessed using a diagnostic tool, considered the ‘gold standard’
in epidemiological studies.
These ﬁndings add to a growing body of evidence that
suggests that DHA may have a protective role for mental health.
DHA only partially explained the protective association
between ﬁsh consumption and depression, suggesting that
other components in ﬁsh may beneﬁt women’s mental health.
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